Homo sapiens Protein: VKORC1
Summary
InnateDB Protein IDBP-240499.5
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol VKORC1
Protein Name vitamin K epoxide reductase complex, subunit 1
Synonyms
Species Homo sapiens
Ensembl Protein ENSP00000378426
InnateDB Gene IDBG-27704 (VKORC1)
Protein Structure
UniProt Annotation
Function Involved in vitamin K metabolism. Catalytic subunit of the vitamin K epoxide reductase (VKOR) complex which reduces inactive vitamin K 2,3-epoxide to active vitamin K. Vitamin K is required for the gamma-carboxylation of various proteins, including clotting factors, and is required for normal blood coagulation, but also for normal bone development. {ECO:0000269PubMed:14765194, ECO:0000269PubMed:14765195, ECO:0000269PubMed:15879509, ECO:0000269PubMed:16270630, ECO:0000269PubMed:20978134, ECO:0000269PubMed:22923610}.
Subcellular Localization Endoplasmic reticulum membrane {ECO:0000269PubMed:14765194, ECO:0000269PubMed:15716279, ECO:0000269PubMed:16270630, ECO:0000269PubMed:20978134, ECO:0000269PubMed:22923610}; Multi-pass membrane protein {ECO:0000269PubMed:14765194, ECO:0000269PubMed:15716279, ECO:0000269PubMed:16270630, ECO:0000269PubMed:20978134, ECO:0000269PubMed:22923610}.
Disease Associations Combined deficiency of vitamin K-dependent clotting factors 2 (VKCFD2) [MIM:607473]: VKCFD leads to a bleeding tendency that is usually reversed by oral administration of vitamin K. {ECO:0000269PubMed:14765194}. Note=The disease is caused by mutations affecting the gene represented in this entry.Coumarin resistance (CMRES) [MIM:122700]: A condition characterized by partial or complete resistance to warfarin or other 4-hydroxycoumarin derivatives. These drugs are used as anti- coagulants for the prevention of thromboembolic diseases in subjects with deep vein thrombosis, atrial fibrillation, or mechanical heart valve replacement. {ECO:0000269PubMed:14765194, ECO:0000269PubMed:20946155}. Note=The disease is caused by mutations affecting the gene represented in this entry.
Tissue Specificity Expressed at highest levels in fetal and adult liver, followed by fetal heart, kidney, and lung, adult heart, and pancreas. {ECO:0000269PubMed:14765194}.
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 91 experimentally validated interaction(s) in this database.
Experimentally validated
Total 91 [view]
Protein-Protein 90 [view]
Protein-DNA 1 [view]
Protein-RNA 0
DNA-DNA 0
RNA-RNA 0
DNA-RNA 0
Gene Ontology

Molecular Function
Accession GO Term
GO:0047057 vitamin-K-epoxide reductase (warfarin-sensitive) activity
GO:0048038 quinone binding
Biological Process
GO:0007596 blood coagulation
GO:0017144 drug metabolic process
GO:0017187 peptidyl-glutamic acid carboxylation
GO:0042373 vitamin K metabolic process
GO:0043687 post-translational protein modification
GO:0044267 cellular protein metabolic process
GO:0055114 oxidation-reduction process
GO:0060348 bone development
Cellular Component
GO:0005789 endoplasmic reticulum membrane
GO:0016021 integral component of membrane
Protein Structure and Domains
PDB ID
InterPro IPR012932 Vitamin K epoxide reductase
PFAM PF07884
PRINTS
PIRSF
SMART SM00756
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt Q9BQB6
PhosphoSite PhosphoSite-Q9BQB6
TrEMBL I3L1P9
UniProt Splice Variant
Entrez Gene 79001
UniGene
RefSeq NP_076869
HUGO HGNC:23663
OMIM 608547
CCDS CCDS10703
HPRD 10540
IMGT
EMBL AC135050 AF176924 AK289790 AK312005 AY358456 AY423044 AY466113 AY521634 AY587020 BC002911 CH471192
GenPept AAH02911 AAQ13668 AAQ88821 AAR28759 AAR82914 AAS01052 AAS83106 BAF82479 BAG34943 EAW52167 EAW52168